The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 ...
EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...
6d
GlobalData on MSNNew CEOs to join Merck KGaA’s executive boardJean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
Israeli drugmaker Teva has appointed former Sandoz and Biogen executive Richard Francis to succeed current CEO Kare Schultz, who is scheduled to retire at the end of this year. Francis ...
New York, New York-- (Newsfile Corp. - February 25, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ: CROX) and ...
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen ...
Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.
Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results